Volume 20, Number 4—April 2014
Research
High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands
Table 2
Characteristic | No. (%) |
---|---|
Sex | |
M | 51 (41.8) |
F | 71 (58.2) |
Clinical finding | |
Traveler’s diarrhea | 45 (36.9) |
Antimicrobial drug use | 15 (12.3) |
Region visited | |
Southeast Asia | 28 (23.0) |
Indian subcontinent | 31 (25.4) |
Northern Africa | 16 (13.1) |
Southern Africa | 17 (13.9) |
Southern Europe | 6 (4.9) |
Central America | 4 (3.3) |
South America | 6 (4.9) |
Other/multiple | 7 (5.7) |
*Median age, y (range) of travelers was 42.7 (18–72) and median travel duration, (range) was 21.0 (5-20) months. Countries in respective regions are as follows: Southeast Asia (Indonesia, Philippines, Malaysia, Myanmar, Cambodia, Thailand, Vietnam), Indian subcontinent (India, Nepal, Sri Lanka), northern Africa (Canary Islands, Egypt, Gambia, Ghana, Togo, Morocco, Senegal, Uganda), southern Africa (Namibia, Kenya, Tanzania, Zanzibar, Mauritius, South Africa), Central America (Panama, Costa Rica, Mexico), South America (Argentine, Bolivia, Brazil, Columbia, Peru, Suriname), southern Europe (Croatia, Spain, Turkey), other (Australia, Fiji, New Zealand, Oman).
*These authors contributed equally to this article and are co–first authors.
Page created: March 12, 2014
Page updated: March 12, 2014
Page reviewed: March 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.